[ET Net News Agency, 20 June 2017] Bloomage BioTechnology (00963) said offeror Grand
Full Development Limited proposes to take Bloomage BioTechnology private by way of a
scheme of arrangement.
The cancellation price of HK$16.3 represents a premium of about 13.99% over the closing
price of HK$14.3. The cancellation price will not be increased, and the offeror does not
reserve the right to do so. The scheme shares are in aggregate valued at about HK$2,952.11
million.
The offeror is directly and wholly owned by Zhao Yan, the chairman and an executive
director of Bloomage BioTechnology.
Bloomage BioTechnology will apply to the Stock Exchange for the withdrawal of the
listing of the shares on the Stock Exchange immediately following the scheme becoming
effective. The offeror intends that the Group will continue to operate its business in its
current state in the short term.
Bloomage BioTechnology had applied for the resumption of trading in shares this morning.
(HL)
|
|
|
|
|
|
|
|
|
|
IPO News
20/06/2017 08:41
Bloomage BioTec (00963) chairman plans privatisation